Source: Annual Congress 2010 - Pre-clinical models of airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. de Paula Vieira, T. Muller, J. Christian Virchow, Jr., V. Gernler, M. Grimm, S. Cicko, T. Durk, S. Sorichter, R. Zeiser, M. Idzko (Rostock, Germany). Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling. Eur Respir J 2010; 36: Suppl. 54, 5148

Member's Comments

No comment yet.

Related content which might interest you: IL-33/sST2 balance regulates neutrophilic inflammation in the human airways. Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002 Evidence for secretion of IL-18 in asthmatic airway inflammation assessed by endobronchial allergen challenge and its relationship to accumulation of inflammatory cells Source: Eur Respir J 2001; 18: Suppl. 33, 531s Year: 2001 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013 Airway G-CSF identifies neutrophilic inflammation and contributes to asthma progression Source: Eur Respir J, 55 (2) 1900827; 10.1183/13993003.00827-2019 Year: 2020 Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in COPD Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 IL-33 blockade impacts mediators of persistence and exacerbation of chronic airway inflammation. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012 Allergen-induced BDNF expression and neuronal remodeling contributes to airway hyperresponsiveness Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 A role for Th1 cells in airway remodeling and hyperreactivity in mice subjected to chronic allergen exposure Source: Eur Respir J 2007; 30: Suppl. 51, 734s Year: 2007 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 Let-7 promotes airway remodeling via regulation of IL-6 in chronic obstruction pulmonary disease Source: Virtual Congress 2020 – Respiratory homeostasis and structural changes in disease Year: 2020 Aerobic exercise reduces allergic airway inflammation and remodeling by deactivating airway epithelial cells and leukocytes Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011